Annual Accounts Payable
$9.86 M
+$786.00 K+8.66%
December 31, 2023
Summary
- As of February 24, 2025, ANIK annual accounts payable is $9.86 million, with the most recent change of +$786.00 thousand (+8.66%) on December 31, 2023.
- During the last 3 years, ANIK annual accounts payable has risen by +$876.00 thousand (+9.75%).
- ANIK annual accounts payable is now at all-time high.
Performance
ANIK Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$6.80 M
-$3.19 M-31.91%
September 30, 2024
Summary
- As of February 24, 2025, ANIK quarterly accounts payable is $6.80 million, with the most recent change of -$3.19 million (-31.91%) on September 30, 2024.
- Over the past year, ANIK quarterly accounts payable has stayed the same.
- ANIK quarterly accounts payable is now -32.10% below its all-time high of $10.02 million, reached on March 31, 2024.
Performance
ANIK Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ANIK Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.7% | 0.0% |
| 3 y3 years | +9.8% | -14.3% |
| 5 y5 years | +213.7% | +151.8% |
ANIK Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +29.2% | -32.1% | at low |
| 5 y | 5-year | at high | +157.3% | -32.1% | +77.6% |
| alltime | all time | at high | +2725.2% | -32.1% | +2168.3% |
Anika Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.80 M(-31.9%) |
| Jun 2024 | - | $9.99 M(-0.3%) |
| Mar 2024 | - | $10.02 M(+1.6%) |
| Dec 2023 | $9.86 M(+8.7%) | $9.86 M(+19.5%) |
| Sep 2023 | - | $8.25 M(+3.9%) |
| Jun 2023 | - | $7.94 M(-11.2%) |
| Mar 2023 | - | $8.95 M(-1.4%) |
| Dec 2022 | $9.07 M(+18.9%) | $9.07 M(+8.6%) |
| Sep 2022 | - | $8.35 M(+2.3%) |
| Jun 2022 | - | $8.16 M(+9.7%) |
| Mar 2022 | - | $7.44 M(-2.5%) |
| Dec 2021 | $7.63 M(-15.0%) | $7.63 M(-3.9%) |
| Sep 2021 | - | $7.94 M(-2.0%) |
| Jun 2021 | - | $8.10 M(-6.7%) |
| Mar 2021 | - | $8.68 M(-3.4%) |
| Dec 2020 | $8.98 M(+134.4%) | $8.98 M(+32.1%) |
| Sep 2020 | - | $6.80 M(+10.4%) |
| Jun 2020 | - | $6.16 M(-37.8%) |
| Mar 2020 | - | $9.91 M(+158.5%) |
| Dec 2019 | $3.83 M(+21.9%) | $3.83 M(+41.8%) |
| Sep 2019 | - | $2.70 M(+18.1%) |
| Jun 2019 | - | $2.29 M(-36.0%) |
| Mar 2019 | - | $3.57 M(+13.6%) |
| Dec 2018 | $3.14 M(-53.4%) | $3.14 M(+27.7%) |
| Sep 2018 | - | $2.46 M(-51.5%) |
| Jun 2018 | - | $5.07 M(-17.6%) |
| Mar 2018 | - | $6.16 M(-8.7%) |
| Dec 2017 | $6.75 M(+193.0%) | $6.75 M(+30.0%) |
| Sep 2017 | - | $5.19 M(-5.1%) |
| Jun 2017 | - | $5.46 M(-9.7%) |
| Mar 2017 | - | $6.05 M(+162.7%) |
| Dec 2016 | $2.30 M(-72.3%) | $2.30 M(+18.2%) |
| Sep 2016 | - | $1.95 M(-40.8%) |
| Jun 2016 | - | $3.29 M(+1.0%) |
| Mar 2016 | - | $3.26 M(-60.7%) |
| Dec 2015 | $8.30 M(+591.3%) | $8.30 M(+273.8%) |
| Sep 2015 | - | $2.22 M(+34.0%) |
| Jun 2015 | - | $1.66 M(-6.6%) |
| Mar 2015 | - | $1.77 M(+47.8%) |
| Dec 2014 | $1.20 M(-57.0%) | $1.20 M(+2.9%) |
| Sep 2014 | - | $1.17 M(-46.9%) |
| Jun 2014 | - | $2.20 M(-19.9%) |
| Mar 2014 | - | $2.74 M(-1.8%) |
| Dec 2013 | $2.79 M(+19.3%) | $2.79 M(+30.8%) |
| Sep 2013 | - | $2.14 M(-20.9%) |
| Jun 2013 | - | $2.70 M(+0.1%) |
| Mar 2013 | - | $2.70 M(+15.1%) |
| Dec 2012 | $2.34 M(-45.5%) | $2.34 M(+22.8%) |
| Sep 2012 | - | $1.91 M(-51.6%) |
| Jun 2012 | - | $3.94 M(+1.6%) |
| Mar 2012 | - | $3.88 M(-9.7%) |
| Dec 2011 | $4.30 M(-55.6%) | $4.30 M(+12.1%) |
| Sep 2011 | - | $3.84 M(-49.4%) |
| Jun 2011 | - | $7.59 M(-17.2%) |
| Mar 2011 | - | $9.16 M(-5.5%) |
| Dec 2010 | $9.69 M(+52.6%) | $9.69 M(+5.8%) |
| Sep 2010 | - | $9.16 M(+23.6%) |
| Jun 2010 | - | $7.41 M(+5.7%) |
| Mar 2010 | - | $7.01 M(+10.4%) |
| Dec 2009 | $6.35 M(+167.5%) | $6.35 M(+420.6%) |
| Sep 2009 | - | $1.22 M(-31.0%) |
| Jun 2009 | - | $1.77 M(-13.1%) |
| Mar 2009 | - | $2.04 M(-14.3%) |
| Dec 2008 | $2.38 M | $2.38 M(-13.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2008 | - | $2.74 M(-13.0%) |
| Jun 2008 | - | $3.15 M(+101.2%) |
| Mar 2008 | - | $1.56 M(-67.9%) |
| Dec 2007 | $4.87 M(+404.2%) | $4.87 M(+16.3%) |
| Sep 2007 | - | $4.18 M(+60.0%) |
| Jun 2007 | - | $2.62 M(+139.7%) |
| Mar 2007 | - | $1.09 M(+13.1%) |
| Dec 2006 | $965.20 K(-24.5%) | $965.20 K(+22.9%) |
| Sep 2006 | - | $785.20 K(-24.7%) |
| Jun 2006 | - | $1.04 M(+32.0%) |
| Mar 2006 | - | $789.30 K(-38.2%) |
| Dec 2005 | $1.28 M(+61.5%) | $1.28 M(-22.8%) |
| Sep 2005 | - | $1.66 M(+334.6%) |
| Jun 2005 | - | $381.00 K(-51.5%) |
| Mar 2005 | - | $786.00 K(-0.6%) |
| Dec 2004 | $791.00 K(+126.6%) | $791.00 K(-5.4%) |
| Sep 2004 | - | $836.00 K(+42.4%) |
| Jun 2004 | - | $587.00 K(-27.1%) |
| Mar 2004 | - | $805.00 K(+130.7%) |
| Dec 2003 | $349.00 K(-58.7%) | $349.00 K(-18.5%) |
| Sep 2003 | - | $428.00 K(+5.4%) |
| Jun 2003 | - | $406.00 K(-43.5%) |
| Mar 2003 | - | $719.00 K(-14.9%) |
| Dec 2002 | $845.00 K(-11.5%) | $845.00 K(+8.7%) |
| Sep 2002 | - | $777.10 K(+1.5%) |
| Jun 2002 | - | $765.90 K(+9.0%) |
| Mar 2002 | - | $702.80 K(-26.4%) |
| Dec 2001 | $954.60 K(+9.7%) | $954.60 K(+8.3%) |
| Sep 2001 | - | $881.10 K(-46.7%) |
| Jun 2001 | - | $1.65 M(+113.4%) |
| Mar 2001 | - | $773.80 K(-11.1%) |
| Dec 2000 | $870.50 K(+45.1%) | $870.50 K(+82.0%) |
| Sep 2000 | - | $478.20 K(-63.5%) |
| Jun 2000 | - | $1.31 M(+210.7%) |
| Mar 2000 | - | $421.40 K(-29.8%) |
| Dec 1999 | $600.00 K(-33.3%) | $600.00 K(-14.3%) |
| Sep 1999 | - | $700.00 K(-12.5%) |
| Jun 1999 | - | $800.00 K(-38.5%) |
| Mar 1999 | - | $1.30 M(+44.4%) |
| Dec 1998 | $900.00 K(-10.0%) | $900.00 K(+28.6%) |
| Sep 1998 | - | $700.00 K(-22.2%) |
| Jun 1998 | - | $900.00 K(+28.6%) |
| Mar 1998 | - | $700.00 K(-30.0%) |
| Dec 1997 | $1.00 M(+66.7%) | $1.00 M(+25.0%) |
| Sep 1997 | - | $800.00 K(+60.0%) |
| Jun 1997 | - | $500.00 K(-28.6%) |
| Mar 1997 | - | $700.00 K(+16.7%) |
| Dec 1996 | $600.00 K(0.0%) | - |
| Nov 1996 | - | $600.00 K(0.0%) |
| Aug 1996 | - | $600.00 K(+50.0%) |
| Aug 1996 | $600.00 K(+50.0%) | - |
| May 1996 | - | $400.00 K(-33.3%) |
| Feb 1996 | - | $600.00 K(+20.0%) |
| Nov 1995 | - | $500.00 K(+25.0%) |
| Aug 1995 | $400.00 K(-20.0%) | $400.00 K(-20.0%) |
| May 1995 | - | $500.00 K(+66.7%) |
| Feb 1995 | - | $300.00 K(-25.0%) |
| Nov 1994 | - | $400.00 K(-20.0%) |
| Aug 1994 | $500.00 K(-50.0%) | $500.00 K(0.0%) |
| May 1994 | - | $500.00 K(+66.7%) |
| Feb 1994 | - | $300.00 K(-62.5%) |
| Nov 1993 | - | $800.00 K(-20.0%) |
| Aug 1993 | $1.00 M | $1.00 M(+233.3%) |
| May 1993 | - | $300.00 K |
FAQ
- What is Anika Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Anika Therapeutics?
- What is Anika Therapeutics annual accounts payable year-on-year change?
- What is Anika Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Anika Therapeutics?
- What is Anika Therapeutics quarterly accounts payable year-on-year change?
What is Anika Therapeutics annual accounts payable?
The current annual accounts payable of ANIK is $9.86 M
What is the all time high annual accounts payable for Anika Therapeutics?
Anika Therapeutics all-time high annual accounts payable is $9.86 M
What is Anika Therapeutics annual accounts payable year-on-year change?
Over the past year, ANIK annual accounts payable has changed by +$786.00 K (+8.66%)
What is Anika Therapeutics quarterly accounts payable?
The current quarterly accounts payable of ANIK is $6.80 M
What is the all time high quarterly accounts payable for Anika Therapeutics?
Anika Therapeutics all-time high quarterly accounts payable is $10.02 M
What is Anika Therapeutics quarterly accounts payable year-on-year change?
Over the past year, ANIK quarterly accounts payable has changed by $0.00 (0.00%)